Choriogonadotropin β Polyclonal Antibody
- Catalog No.:YT0913
- Applications:WB;IHC;IF;ELISA
- Reactivity:Human;Rat;Mouse;
- Target:
- Choriogonadotropin β
- Gene Name:
- CGB
- Protein Name:
- Choriogonadotropin subunit beta
- Human Gene Id:
- 1082/93659/94027/94115
- Human Swiss Prot No:
- P01233
- Immunogen:
- The antiserum was produced against synthesized peptide derived from human hCG beta. AA range:101-150
- Specificity:
- Choriogonadotropin β Polyclonal Antibody detects endogenous levels of Choriogonadotropin β protein.
- Formulation:
- Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.
- Source:
- Polyclonal, Rabbit,IgG
- Dilution:
- WB 1:500 - 1:2000. IHC 1:100 - 1:300. ELISA: 1:10000.. IF 1:50-200
- Purification:
- The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
- Concentration:
- 1 mg/ml
- Storage Stability:
- -15°C to -25°C/1 year(Do not lower than -25°C)
- Other Name:
- CGB;CGB3;CGB5;CGB7;CGB8;Choriogonadotropin subunit beta;CG-beta;Chorionic gonadotrophin chain beta
- Observed Band(KD):
- 20kD
- Background:
- This gene is a member of the glycoprotein hormone beta chain family and encodes the beta 3 subunit of chorionic gonadotropin (CG). Glycoprotein hormones are heterodimers consisting of a common alpha subunit and an unique beta subunit which confers biological specificity. CG is produced by the trophoblastic cells of the placenta and stimulates the ovaries to synthesize the steroids that are essential for the maintenance of pregnancy. The beta subunit of CG is encoded by 6 genes which are arranged in tandem and inverted pairs on chromosome 19q13.3 and contiguous with the luteinizing hormone beta subunit gene. [provided by RefSeq, Jul 2008],
- Function:
- developmental stage:Made by the first trimester placenta.,function:Stimulates the ovaries to synthesize the steroids that are essential for the maintenance of pregnancy.,online information:Chorionic gonadotropin entry,pharmaceutical:Available under the names Novarel (Ferring) and Profasi (Serono). Used as adjunctive therapy in the treatment of obesity. There is no substantial evidence that it increases weight loss beyond that resulting from caloric restriction, that it causes a more attractive or 'normal' distribution of fat, or that it decreases the hunger and discomfort associated with calorie-restricted diets.,similarity:Belongs to the glycoprotein hormones subunit beta family.,subunit:Heterodimer of a common alpha chain and a unique beta chain which confers biological specificity to thyrotropin, lutropin, follitropin and gonadotropin.,tissue specificity:Placenta.,
- Subcellular Location:
- extracellular region,
- Expression:
- Brain,Placenta,
- June 19-2018
- WESTERN IMMUNOBLOTTING PROTOCOL
- June 19-2018
- IMMUNOHISTOCHEMISTRY-PARAFFIN PROTOCOL
- June 19-2018
- IMMUNOFLUORESCENCE PROTOCOL
- September 08-2020
- FLOW-CYTOMEYRT-PROTOCOL
- May 20-2022
- Cell-Based ELISA│解您多样本WB检测之困扰
- July 13-2018
- CELL-BASED-ELISA-PROTOCOL-FOR-ACETYL-PROTEIN
- July 13-2018
- CELL-BASED-ELISA-PROTOCOL-FOR-PHOSPHO-PROTEIN
- July 13-2018
- Antibody-FAQs
- Products Images
- Western Blot analysis of KB cells using Choriogonadotropin β Polyclonal Antibody diluted at 1:2000
- Immunohistochemistry analysis of paraffin-embedded human breast carcinoma tissue, using hCG beta Antibody. The picture on the right is blocked with the synthesized peptide.
- Western blot analysis of lysates from NIH/3T3 cells, using hCG beta Antibody. The lane on the right is blocked with the synthesized peptide.